Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. (Q52539875)

2 May 2018

title

Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. (English)

1 reference

2 May 2018

0 references

Dimitriadou V

1

1 reference

2 May 2018

Pang X

series ordinal

2

1 reference

2 May 2018

Theoharides TC

series ordinal

3

1 reference

2 May 2018

publication date

1 September 2000

1 reference

2 May 2018

International Journal of Immunopharmacology

published in

1 reference

2 May 2018

volume

22

1 reference

2 May 2018

issue

9

1 reference

2 May 2018

page(s)

673-684

1 reference

2 May 2018

Pathogenesis of multiple sclerosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

The relationship between human multiple sclerosis and rodent experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Presence and distribution of nervous system-associated mast cells that may modulate experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cells in brains during experimental allergic encephalomyelitis in Lewis rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cells in plaques of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

The mast cells of the multiple sclerosis brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cell proteases liberate stable encephalitogenic fragments from intact myelin

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Identification of a committed precursor for the mast cell lineage.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

New concepts about the mast cell

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Migration of mast cells in the developing rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Histochemical and ultrastructural characteristics of rat brain perivascular mast cells stimulated with compound 48/80 and carbachol

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cells in mammalian brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Regional distribution of mast cells containing histamine, dopamine, or 5-hydroxytryptamine in the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cells in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

The mast cells of the mammalian central nervous system. III. Ultrastructural characteristics in the adult rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cells in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Definitive characterization of rat hypothalamic mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Ultrastructural evidence for a functional unit between nerve fibers and type II cerebral mast cells in the cerebral vascular wall

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Influence of the sympathetic nervous system as well as trigeminal sensory fibres on rat dural mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cells: the immune gate to the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Brain mast cell degranulation regulates blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Hydroxyzine inhibits neurogenic bladder mast cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Dermatitis characterized by mastocytosis at immunization sites in mast-cell-deficient W/Wv mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Delayed-type hypersensitivity: activation of mast cells by antigen-specific T-cell factors initiates the cascade of cellular interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Inhibitory effect of hydroxyzine on antigen-induced histamine release in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Attenuation of experimental autoimmune encephalomyelitis by Compound 48/80 in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Dermal mast cell degranulation in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Experimental Autoimmune Demyelination: Chronic Relapsing Models and Their Therapeutic Implications for Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cells increase in tissues of neonatal rats injected with the nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Nerve growth factor promotes human hemopoietic colony growth and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

The blood-brain barrier and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mediators of immediate hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Leakiness of rat brain microvessels to fluorescent probes following craniotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Permeability and vasomotor response of cerebral vessels during exposure to arachidonic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Blood-brain barrier permeability and vascular reactivity to bradykinin after pretreatment with dexamethasone.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Changes in blood-brain barrier and cerebral blood flow following elevation of circulating serotonin level in anesthetized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Mast cells as a source of multifunctional cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Evidence that brain mast cells can modulate neuroinflammatory responses by tumour necrosis factor-alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

TNF-alpha transgenic and knockout models of CNS inflammation and degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Increased levels of intercellular adhesion molecule-1 (ICAM-1) and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Relapsing autoimmune demyelination: a role for vascular addressins

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Rat cerebral mast cells undergo phenotypic changes during development.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Intramuscular injection of hrRANTES causes mast cell recruitment and increased transcription of histidine decarboxylase in mice: lack of effects in genetically mast cell-deficient W/WV mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Brain mast cells lack the c-kit receptor: immunocytochemical evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2800%2900029-1

7 January 2021

10.1016/S0192-0561(00)00029-1

Identifiers

DOI

1 reference

2 May 2018

PubMed ID

10884588

1 reference

2 May 2018